SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 211 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 3.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $984 | -3.8% | 35,678 | +4.8% | 0.00% | 0.0% |
Q2 2023 | $1,023 | -23.1% | 34,031 | -7.4% | 0.00% | -40.0% |
Q1 2023 | $1,331 | +5.0% | 36,744 | +3.4% | 0.01% | 0.0% |
Q4 2022 | $1,268 | -99.9% | 35,550 | +2.2% | 0.01% | 0.0% |
Q3 2022 | $1,178,000 | +22.3% | 34,795 | +4.5% | 0.01% | +25.0% |
Q2 2022 | $963,000 | -4.3% | 33,298 | +7.0% | 0.00% | 0.0% |
Q1 2022 | $1,006,000 | +27.8% | 31,126 | +15.3% | 0.00% | +33.3% |
Q4 2021 | $787,000 | +33.8% | 26,997 | +22.5% | 0.00% | +50.0% |
Q3 2021 | $588,000 | -2.6% | 22,044 | +12.3% | 0.00% | -33.3% |
Q2 2021 | $604,000 | +43.5% | 19,625 | +21.9% | 0.00% | +50.0% |
Q1 2021 | $421,000 | +3.4% | 16,100 | -0.6% | 0.00% | 0.0% |
Q4 2020 | $407,000 | +57.1% | 16,196 | +30.4% | 0.00% | 0.0% |
Q3 2020 | $259,000 | -22.5% | 12,422 | -11.6% | 0.00% | 0.0% |
Q2 2020 | $334,000 | -73.0% | 14,045 | -73.1% | 0.00% | -77.8% |
Q4 2019 | $1,237,000 | -30.7% | 52,152 | -19.7% | 0.01% | -35.7% |
Q3 2019 | $1,785,000 | -32.5% | 64,945 | -18.7% | 0.01% | -36.4% |
Q2 2019 | $2,643,000 | +314.9% | 79,877 | +210.3% | 0.02% | +175.0% |
Q3 2016 | $637,000 | +31.9% | 25,746 | +8.6% | 0.01% | +14.3% |
Q2 2016 | $483,000 | – | 23,701 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 335,000 | $8,934,000 | 13.38% |
ASHFORD CAPITAL MANAGEMENT INC | 1,016,665 | $27,114,000 | 2.46% |
Bruce & Co., Inc. | 402,105 | $10,724,000 | 2.28% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $7,934,000 | 1.91% |
ARMISTICE CAPITAL, LLC | 3,900,000 | $104,013,000 | 1.76% |
Bridge City Capital, LLC | 108,884 | $2,904,000 | 1.32% |
S&T BANK/PA | 316,098 | $8,430,000 | 1.31% |
Kent Lake Capital LLC | 100,000 | $2,667,000 | 1.15% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 331,140 | $8,832,000 | 1.02% |
Prairiewood Capital, LLC | 45,297 | $1,208,000 | 0.99% |